Classification: Public
Hi,
Your writing is ok. Please find below
my comments:
- Please send me word files next time
so I could add my comments directly on the writing.
- Business Description: will be rewritten
when you know more about the company.
- Industry Overview:
*
What are 3 tiers? and the third including VN?
*
Where did you get the growth rate anticipation of 20% for 5 years?
*
I am not sure about your conclusion about CPI growth rates of pharma and
total.
*
I need a comparison of spending on health care/total income person of Vietnam,
regional countries and developed countries.
*
Could you remake the chart 2? I couldn't see the details.
*
Do you have the break down of the industry revenue? (by companies, by products
...)
*
How's about the functional food? I think it's a new trend.
*
Where is the part about the commission system?
*What
happens to VN pharma industry with patent cliff?
*
The part about WTO and price control policies are not clear. Could you
please explain more?
*
How's about overall R&D spending? and recent M&A.
I think we should meet next week? an
evening after work (not the Wed 10) or next Sat 13 afternoon. Please pick
a day.
Thanks & Best Regards
Chu Hoang Viet
Global Markets
Deutsche Bank AG Hochiminh City
Add: 13th floor, Saigon Centre, 65 Le Loi Boulevard
Direct line: 84-8-6299-8820 & 8821
Tel: 84-8-6299-8800
Fax:84-8-3829-3865
Cellphone: 84-982196189
E-mail: chu-hoa...@db.com
Hi Mr.Viet,
This is industry overview part. Since there are so many information, we
are confused in select the best information for the report.
On the other hand, we are stuying company part and try to complete
it this sunday.
Have a nice day.
Best regards,
Trần Ğặng Phıõng Oanh
[attachment "UEL'S REPORT.pdf"
deleted by Chu-Hoang Viet/ext/dbcom]
---
This e-mail may contain confidential and/or privileged information. If you
are not the intended recipient (or have received this e-mail in error)
please notify the sender immediately and destroy this e-mail. Any
unauthorized copying, disclosure or distribution of the material in this
e-mail is strictly forbidden.
--